N. Sato

Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.

M. Ebisawa, T. Fujisawa, S. Nishima, 2015, Allergology international : official journal of the Japanese Society of Allergology.

Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen‐induced seasonal allergic rhinitis

K. Okubo, T. Nagakura, N. Sato, 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: a randomized study.

K. Okubo, R. Fogel, M. Okano, 2020, The journal of allergy and clinical immunology. In practice.

One year treatment with omalizumab is effective and well tolerated in Japanese Patients with moderate-to-severe persistent asthma.

K. Ohta, T. Miyamoto, N. Sato, 2010, Allergology international : official journal of the Japanese Society of Allergology.

Re-Treatment with Omalizumab at One Year Interval for Japanese Cedar Pollen-Induced Seasonal Allergic Rhinitis Is Effective and Well Tolerated

K. Okubo, T. Nagakura, N. Sato, 2009, International Archives of Allergy and Immunology.

Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma.

M. Ebisawa, T. Fujisawa, S. Nishima, 2017, Allergology international : official journal of the Japanese Society of Allergology.